The 20 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 351.50, with a high estimate of 412.00 and a low estimate of 202.00. The median estimate represents a +6.51% increase from the last price of 330.01.
The current consensus among 22 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.93
Reporting Date Nov 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.